ethyl [(2R,3S,4S,6S)-3,4,5-trihydroxy-6-[2-[(4-methoxyphenyl)methyl]phenoxy]oxan-2-yl]methyl carbonate

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ethyl [(2R,3S,4S,6S)-3,4,5-trihydroxy-6-[2-[(4-methoxyphenyl)methyl]phenoxy]oxan-2-yl]methyl carbonate
• 化学式: C₂₃H₂₈O₉
• 分子量: 448.5
• InChiKey: QLXKHBNJTPICNF-ZHXVYXOISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  32
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  124
• 氢给体数：
  3
• 氢受体数：
  9

文献信息

• ANNELATED PYRROLIDIN SULFONAMIDES WITH OXADIAZOLONE HEADGROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
  申请人：SANOFI

  公开号：EP2288605B1

  公开（公告）日：2014-06-25
• [EN] A CRYSTALLINE HETEROAROMATIC FLUOROGLYCOSIDE HYDRATE, PROCESSES FOR MAKING, METHODS OF USE AND PHARMACEUTICAL COMPOSITIONS THEREOF<br/>[FR] HYDRATE DE FLUOROGLYCOSIDE HÉTÉROAROMATIQUE CRISTALLIN, SES PROCÉDÉS DE FABRICATION, SES PROCÉDÉS D'UTILISATION ET COMPOSITIONS PHARMACEUTIQUES LE CONTENANT
  申请人：SANOFI AVENTIS

  公开号：WO2010068601A1

  公开（公告）日：2010-06-17

  A novel crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof. The invention relates to a crystalline hydrate of the formula (I) in which n has a value of from 0.9 to 1.1. The compound is suitable, for example, as an antidiabetic.